Models
CCME GLOBAL LIMITEDBSE 514336Pharmaceuticals & Biotechnology
-152per share · Base Model Note
Revenue growth, the horizon and scenarios are yours to change. Every other input is part of the Trader plan; saving, sharing a saved link and the live-formula workbook are part of the Institutional plan.
Scenario
Value per share, your model(152)implied P/B (17.19)× on FY26 book
Against CMP ₹30.00606.6%close of 2026-09-10
Cost of equity5.30%risk-free + beta × equity risk premium
Book equity, FY269per share · excess returns add ₹(161)
This figure is the arithmetic of your inputs and nothing else. MarketPing publishes no fair value, target or rating; the model is yours.

Excess-return schedule · ₹ crore · book equity earns your ROE; value is book plus the returns above the cost of equity

₹ croreFY27FY28FY29FY30FY31
Opening book equity4039393837
Net income at -1.8% ROE(1)(1)(1)(1)(1)
Cost of equity charge at 5.30%(2)(2)(2)(2)(2)
Excess return(3)(3)(3)(3)(3)
Present value(3)(3)(2)(2)(2)
Closing book equity3939383737
Book equity today40
PV of 5 years of excess return(12)
PV of the terminal excess return, 5% flat(716)
add non-operating investments0
Equity value(688)
÷ 4.53 crore shares(152)
ROE is at or below the cost of equity, so every year destroys value against book and the model lands below book value. That is the arithmetic, not a view.

Where the methods land · ₹ per share · the dashed line is the CMP

52-week rangetraded range, a fact not a value
26185

Scenarios side by side · ₹ per share

ScenarioTemplateGrowthMarginRateTerminal₹ / sharevs CMP
Base · editingExcess returnROE -1.8%5.30%5%(152)(606.6)%
A scenario is a full set of inputs under a name. Keep Base as the filed history carried forward; add Bull and Bear by saving the current inputs under those names and moving the two or three assumptions you actually hold a view on. The distribution above draws each driver between the lowest and highest value across your scenarios, so three scenarios give it a real range; with one scenario it falls back to fixed bands.